Enhancing liver fibrosis diagnosis and treatment assessment: a novel biomechanical markers-based machine learning approach.

Journal: Physics in medicine and biology
PMID:

Abstract

Accurate diagnosis and treatment assessment of liver fibrosis face significant challenges, including inherent limitations in current techniques like sampling errors and inter-observer variability. Addressing this, our study introduces a novel machine learning (ML) framework, which integrates light gradient boosting machine and multivariate imputation by chained equations to enhance liver status assessment using biomechanical markers. Building upon our previously established multiscale mechanical characteristics in fibrotic and treated livers, this framework employs Gaussian Bayesian optimization for post-imputation, significantly improving classification performance. Our findings indicate a marked increase in the precision of liver fibrosis diagnosis and provide a novel, quantitative approach for assessing fibrosis treatment. This innovative combination of multiscale biomechanical markers with advanced ML algorithms represents a transformative step in liver disease diagnostics and treatment evaluation, with potential implications for other areas in medical diagnostics.

Authors

  • Zhuo Chang
    Laboratory for Multiscale Mechanics and Medical Science, Department of Engineering Mechanics, SVL, School of Aerospace Engineering, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.
  • Chen-Hao Peng
    Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung 41170, Taiwan, R.O.C.
  • Kai-Jung Chen
    Department of Mechanical Engineering, National Chin-Yi University of Technology, Taichung 41170, Taiwan, R.O.C.
  • Guang-Kui Xu
    Laboratory for Multiscale Mechanics and Medical Science, Department of Engineering Mechanics, SVL, School of Aerospace Engineering, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.